Finance

Lists
Why is 002793 up 2.26%?
Dive Deeper
002793:SHE
Luoxin Pharmaceuticals Group Stock CoLtd
CNÂ¥4.08
+2.26%
(+0.090) 1D
Nov 4, 3:04:30 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002793...
Open
CNÂ¥3.99
High
CNÂ¥4.08
Low
CNÂ¥3.94
Mkt. cap
4.34B
Avg. vol.
21.99M
Volume
19.21M
52-wk high
CNÂ¥5.82
52-wk low
CNÂ¥3.70
EPS
-CNÂ¥0.24
Shares outstanding
1.09B
No. of employees
3K
Open
CNÂ¥3.99
High
CNÂ¥4.08
Low
CNÂ¥3.94
Mkt. cap
4.34B
Avg. vol.
21.99M
Volume
19.21M
52-wk high
CNÂ¥5.82
52-wk low
CNÂ¥3.70
EPS
-CNÂ¥0.24
Shares outstanding
1.09B
No. of employees
3K
News stories
From web sources and news partners
About Luoxin Pharmaceuticals Group Stock CoLtd
CEO-
Employees2.96K
FoundedMay 11, 1998
Headquarters-
SectorPharmaceutical industry
Industry-
Websiteluoxin.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
550.04M
582.73M
564.73M
532.17M
Cost of goods sold
350.41M
227.21M
233.14M
245.25M
Cost of revenue
350.41M
227.21M
233.14M
245.25M
Research and development expenses
28.30M
18.23M
13.81M
16.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
416.72M
293.64M
255.71M
223.08M
Operating expense
473.08M
309.55M
276.59M
249.00M
Total operating expenses
823.49M
536.76M
509.72M
494.25M
Operating income
-273.45M
45.97M
55.00M
37.92M
Other non operating income
5.56M
-892.17K
793.30K
-29.45M
EBT including unusual items
-342.19M
42.70M
30.79M
18.20M
EBT excluding unusual items
-279.55M
48.11M
43.36M
24.07M
Income tax expense
-24.11M
13.70M
6.56M
9.09M
Effective tax rate
7.04%
32.09%
21.29%
49.96%
Other operating expenses
23.50M
3.46M
6.40M
4.58M
Net income
-311.51M
24.15M
25.78M
11.52M
Net profit margin
-56.63%
4.14%
4.57%
2.16%
Earnings per share
-
-
-
-
Interest and investment income
1.02M
16.52M
-
24.36M
Interest expense
-12.19M
-13.48M
-11.80M
-9.39M
Net interest expenses
-11.17M
3.04M
-11.80M
14.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
-224.55M
94.87M
97.95M
86.82M
Gain or loss from assets sale
-3.08M
-
-330.98K
330.98K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps